m5C RNA modification in colorectal cancer: mechanisms and therapeutic targets
Abstract 5-Methylcytosine (m5C), an important RNA modification, has been extensively studied in colorectal cancer (CRC). In recent years, with advances in high-throughput sequencing technology and RNA modification detection tools, the role of m5C modification in tumorigenesis and development has bee...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06985-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849226017826144256 |
|---|---|
| author | Jiawei Wang Cenyi Qi Ran Wang Yuepeng Cao Yuping Zhou Guoliang Ye |
| author_facet | Jiawei Wang Cenyi Qi Ran Wang Yuepeng Cao Yuping Zhou Guoliang Ye |
| author_sort | Jiawei Wang |
| collection | DOAJ |
| description | Abstract 5-Methylcytosine (m5C), an important RNA modification, has been extensively studied in colorectal cancer (CRC). In recent years, with advances in high-throughput sequencing technology and RNA modification detection tools, the role of m5C modification in tumorigenesis and development has been gradually elucidated and regulated by “writers,” “erasers,” and “readers,” m5C modification affects many biological processes and cancer progression, including cell proliferation, autophagy, invasion, and apoptosis. In CRC, m5C modification affects cancer cell proliferation, migration, invasion, drug resistance, and immunotherapy resistance by regulating RNA stability, metabolic reprogramming, signalling pathway activation, and immune escape. Moreover, m5C modification provides potential biomarkers and targets for early diagnosis and efficacy prediction. In addition, studies on drugs that target m5C modification related proteins have shown that intervention in m5C modification may provide new directions for immunotherapy and molecular therapy for patients with CRC. In summary, m5C modification, an important epigenetic regulators in CRC, provides a new perspective on the mechanism underlying cancer therapy and precision medicine research. Future research should focus on revealing the specific role of m5C modification in the tumor microenvironment and drug resistance mechanisms and promote its clinical translation in diagnosis and treatment. |
| format | Article |
| id | doaj-art-c8680ee280ef473882b04edfb285b51b |
| institution | Kabale University |
| issn | 1479-5876 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Translational Medicine |
| spelling | doaj-art-c8680ee280ef473882b04edfb285b51b2025-08-24T11:48:17ZengBMCJournal of Translational Medicine1479-58762025-08-0123111710.1186/s12967-025-06985-3m5C RNA modification in colorectal cancer: mechanisms and therapeutic targetsJiawei Wang0Cenyi Qi1Ran Wang2Yuepeng Cao3Yuping Zhou4Guoliang Ye5Department of Gastroenterology, The First Affiliated Hospital of Ningbo UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo UniversityDepartment of Colorectal and Anal Surgery, The First Affiliated Hospital of Ningbo UniversityDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Ningbo UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo UniversityAbstract 5-Methylcytosine (m5C), an important RNA modification, has been extensively studied in colorectal cancer (CRC). In recent years, with advances in high-throughput sequencing technology and RNA modification detection tools, the role of m5C modification in tumorigenesis and development has been gradually elucidated and regulated by “writers,” “erasers,” and “readers,” m5C modification affects many biological processes and cancer progression, including cell proliferation, autophagy, invasion, and apoptosis. In CRC, m5C modification affects cancer cell proliferation, migration, invasion, drug resistance, and immunotherapy resistance by regulating RNA stability, metabolic reprogramming, signalling pathway activation, and immune escape. Moreover, m5C modification provides potential biomarkers and targets for early diagnosis and efficacy prediction. In addition, studies on drugs that target m5C modification related proteins have shown that intervention in m5C modification may provide new directions for immunotherapy and molecular therapy for patients with CRC. In summary, m5C modification, an important epigenetic regulators in CRC, provides a new perspective on the mechanism underlying cancer therapy and precision medicine research. Future research should focus on revealing the specific role of m5C modification in the tumor microenvironment and drug resistance mechanisms and promote its clinical translation in diagnosis and treatment.https://doi.org/10.1186/s12967-025-06985-3Colorectal cancerRNA 5-methylcytosine (m5C)NSUN2DNMT2Early diagnosisTargeted therapy |
| spellingShingle | Jiawei Wang Cenyi Qi Ran Wang Yuepeng Cao Yuping Zhou Guoliang Ye m5C RNA modification in colorectal cancer: mechanisms and therapeutic targets Journal of Translational Medicine Colorectal cancer RNA 5-methylcytosine (m5C) NSUN2 DNMT2 Early diagnosis Targeted therapy |
| title | m5C RNA modification in colorectal cancer: mechanisms and therapeutic targets |
| title_full | m5C RNA modification in colorectal cancer: mechanisms and therapeutic targets |
| title_fullStr | m5C RNA modification in colorectal cancer: mechanisms and therapeutic targets |
| title_full_unstemmed | m5C RNA modification in colorectal cancer: mechanisms and therapeutic targets |
| title_short | m5C RNA modification in colorectal cancer: mechanisms and therapeutic targets |
| title_sort | m5c rna modification in colorectal cancer mechanisms and therapeutic targets |
| topic | Colorectal cancer RNA 5-methylcytosine (m5C) NSUN2 DNMT2 Early diagnosis Targeted therapy |
| url | https://doi.org/10.1186/s12967-025-06985-3 |
| work_keys_str_mv | AT jiaweiwang m5crnamodificationincolorectalcancermechanismsandtherapeutictargets AT cenyiqi m5crnamodificationincolorectalcancermechanismsandtherapeutictargets AT ranwang m5crnamodificationincolorectalcancermechanismsandtherapeutictargets AT yuepengcao m5crnamodificationincolorectalcancermechanismsandtherapeutictargets AT yupingzhou m5crnamodificationincolorectalcancermechanismsandtherapeutictargets AT guoliangye m5crnamodificationincolorectalcancermechanismsandtherapeutictargets |